Topics and Expertise: QBI Coronavirus Research Group

QBI and Director Krogan’s COVID and infectious disease efforts continue to make waves

Thu Sep 21, 2023
QBI publishes breakthrough on COVID-19 variants; Nevan Krogan recognized as trailblazer.

UCSF Quantitative Biosciences Institute and Institut Pasteur form center to fight infectious disease

Fri Oct 28, 2022
QBI Director Krogan receives the Legion of Honor, France’s highest award

Danica Fujimori Receives Bowes Biomedical Investigator Award

Fri Sep 18, 2020
Danica Galonić Fujimori, PhD, will receive $1.25 million in funding over the next five years from the endowment of the late William K. Bowes, Jr., a venture capitalist and longtime UCSF supporter.

Nanobody-based antiviral developed at UCSF effectively blocks SARS-CoV-2 in the lab

Wed Aug 12, 2020
School scientists developed an antiviral that fights SARS-CoV-2 that can be given as a nasal spray.

SARS-CoV-2 may spur growth of molecular “railways” out of infected cells, School scientists show

Thu Jul 2, 2020
UCSF-led collaboration uncovers new avenues for COVID-19 drug discovery

QBI Coronavirus Research Group identifies drugs that block SARS-CoV-2 in the laboratory

Thu May 28, 2020
The QBI Coronavirus Research Group found six drugs that effectively beat back SARS-COV-2 in the laboratory.

QBI Coronavirus Research Group races toward a cure

Tue Mar 31, 2020
The UCSF Quantitative Biosciences Institute has made headway identifying dozens of potential therapies for the COVID-19 outbreak.

Hunting for a cure for COVID-19: an insider’s story

Sat Mar 21, 2020
The chief operating officer of the Quantitative Biosciences Institute (QBI) shares a view of the team's work on COVID-19.